MRPL51 and lung carcinoma: Although human evidence in the setting of tumour progression remains unexplored, there are emerging findings of its upregulation in NSCLC cell models, whereby Maiuthed et al. [74] demonstrated >5-fold increase in MRPL51 in a lung cancer cell model.